Aeropay | $20,000,000 | (May 17, 2024)
Bedrock Materials | $9,000,000 | (May 17, 2024)
OTPLESS | $3,500,000 | (May 17, 2024)
DeLorean Artificial Intelligence
United States
- Palm Beach, FL
- 12/09/2023
- Series A
- $7,500,000
DeLorean Artificial Intelligence builds sentient systems of intelligence to address business challenges for Fortune 500 companies by harnessing the ROI from their structured and unstructured data. DeLorean AI currently offers services in the Healthcare Payer, Life Sciences, Life Sciences, Financial, Fintech, M&A, CPG, HR Talent, and Entertainment industries.
DeLorean AI has developed a patent pending predictive and interventive artificial intelligence that has the ability to recognize that a future event with a given probability will happen and how to intervene, whether it be to enhance a good outcome or mitigate a negative impact to a client company.
Please join us on our journey.......
- Industry IT Services and IT Consulting
- Website https://deloreanai.com/
- LinkedIn https://www.linkedin.com/company/delorean-artificial-intelligence/about/
Related People
Severence MacLaughlinFounder
United States -
New York City Metropolitan Area
Dr. MacLaughlin is the Founder & CEO of Delorean Artificial Intelligence (DAI), which produces sentient and semi-sentient systems of intelligence for Sales, CPG, Financial Services, Healthcare, Life Sciences and Natural Resources markets. DAI has successfully submitted and holds Patent Pending rights on a number of Predictive and Interventive AI capabilities. DAI has four AI technologies that are being implemented at clients as well as two services:
1. Customer Relations Management AI (CRM AI) – Predicting sales and revenue, what deals will win and those that fail, what is the next best action to close the deal. This technology sits on any CRM platform (SFDC, Microsoft Dynamics etc.)
2. Real Time Medical Care Management AI (RTMCMAI) – driving better medical decisions for care managers, healthcare professionals and healthcare payers in real time.
3. Customer 360 AI – mathematically modeling who your customer is and how do you communicate to that customer in the right channel at the right time with the right message to drive conversion.
Dr. MacLaughlin is one of the top ranked Life Sciences/Healthcare Data Scientists globally (Ranked among top 20 Life Sciences Data Scientists; Ranked #2 Healthcare Data Scientist; Ranked #1 Consulting Data Scientist in the Life Sciences and Healthcare knowledge base; Recognized as American Healthcare Leader for Q1 2018).
Dr. MacLaughlin has delivered over 40 new disruptive technologies and or implemented Systems of Intelligence resulting in over $1.8B in net present value to customers and an estimated $8B ROI over the next five years.
Severence earned a BS (Magna Cum Laude, Honors & Distinction in Research) at Cornell University, a Doctorate Degree (Honors, Top 1%) from the University of Adelaide and a post-doctoral fellowship at the University of South Australia. Severence has authored over 20 international scientific papers and given invited lectures and conference papers at academic institutions as well as international scientific events.
ekko | $2,500,000 | (May 17, 2024)
Watershed Health | $13,600,000 | (May 17, 2024)
HEPHAISTOS-Pharma | $11,189,199 | (May 17, 2024)
Keyper | $4,000,000 | (May 17, 2024)
c/side | $1,700,000 | (May 17, 2024)
SINE Digital | $2,500,000 | (May 17, 2024)
Angel AI | $4,750,000 | (May 17, 2024)
InstaAstro | $2,300,000 | (May 17, 2024)
Fay | $25,000,000 | (May 16, 2024)